Horizon Investments’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-21
Closed -$1.02K 1503
2025
Q4
$1.02K Buy
+21
New +$1.04K ﹤0.01% 1229
2022
Q3
Sell
-16,138
Closed -$807K 519
2022
Q2
$807K Buy
16,138
+380
+2% +$20.2K 0.03% 210
2022
Q1
$783K Buy
+15,758
New +$814K 0.02% 260
2021
Q3
Sell
-37,606
Closed -$1.98M 513
2021
Q2
$1.98M Buy
+37,606
New +$1.96M 0.06% 147
2019
Q3
Sell
-69,040
Closed -$2.99M 531
2019
Q2
$2.99M Buy
+69,040
New +$2.94M 0.08% 74
2018
Q1
Sell
-22,164
Closed -$1.11M 238
2017
Q4
$1.11M Sell
22,164
-7,280
-25% -$336K 0.07% 96
2017
Q3
$1.48M Buy
29,444
+10,494
+55% +$508K 0.08% 67
2017
Q2
$951K Buy
+18,950
New +$906K 0.06% 74

Other funds holding SNY

Horizon Investments's SNY Position: Q1 2026 in Review

Horizon Investments sold out of Sanofi (SNY) in Q1 2026, closing a stake of 21 shares — an estimated $1.02K sold.

Horizon Investments first reported a position in SNY in Q2 2017 and held it in 8 quarters. The position peaked at $2.99M in Q2 2019. 745 funds tracked by Wall St. Rank hold SNY as of Q1 2026.

  • Horizon Investments reported no remaining Sanofi position as of Q1 2026 after selling out during the quarter.
  • Horizon Investments sold 21 Sanofi shares in Q1 2026, an estimated $1.02K.
  • Horizon Investments first reported a position in Sanofi in Q2 2017 and held it in 8 quarters.
  • Horizon Investments's Sanofi position peaked at $2.99M in Q2 2019.
  • 745 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.

Based on Horizon Investments's 13F filing for Q1 2026, filed 15 May 2026.